IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,714 | -15.9% | 423 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,983 | +391.3% | 423 | 0.0% | 0.00% | – |
| Q1 2023 | $1,625 | -22.5% | 423 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $2,098 | +4.9% | 423 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 423 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 423 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 423 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $3,000 | +50.0% | 423 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 423 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | 0.0% | 423 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | 0.0% | 423 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | 0.0% | 423 | -41.2% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | 0.0% | 720 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +50.0% | 720 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -33.3% | 720 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $3,000 | – | 720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |